On Friday, May 16, 2025, Liberace will host the "Biotech Seminar - Alternatives to Animal Testing Pioneered by Biotech Ventures & Researchers".

　There is a growing trend to abolish animal testing in research and development, particularly in cosmetics and food companies. Under these circumstances, the development and use of model systems using human cells is attracting even more attention. The advantages of human models are not only that animal testing can be avoided, but they are also paving the way for a better understanding of human responses.

　In response, LIVERNESS will hold an online seminar inviting a venture company that has established an immune response evaluation model using human blood cells and a researcher who has established a co-culture model of skin and indigenous skin bacteria. This seminar is intended for companies interested in animal testing alternatives, especially those who are in the process of formulating strategies for their research laboratories. We also welcome the participation of companies interested in collaborating with venture companies and academia researchers through the development and utilization of such alternative animal testing technologies.

　This is an excellent opportunity to gain an in-depth understanding of the latest technological trends and future possibilities for animal substitution methods.

(* If you do not have a LIVERNESS IDthis way (direction close to the speaker or towards the speaker)(Please register for the seminar after registering at)

.

• Date & Time: (date/time) Friday, May 16, 2025 17:00-18:00
• Format: A Online (URL will be sent to you after registration)
• Subjects:.
  • Company researchers interested in animal replacement experiments 
  • You are in charge of the strategy of a company's research center
  • Companies looking for possibilities to collaborate with bio-ventures and researchers
• Participation fee: $25.00 free
• Timeline:.
  • Purpose Statement / Recent Trends in Alternative Methods for Animal Experiments
  • Speaker Presentations - Introduction of cutting-edge technology
    • Mr. Kazuo Miyazaki (CEO, MyCan Technologies, Inc.)
    • Yuki Furuyama (Assistant Professor, Department of Life Science and Biological Sciences, Tokyo University of Science)
  • Discussion & Q&A
  • summary
• Application Form:https://lne.st/250516_bio

(* If you do not have a LIVERNESS IDthis way (direction close to the speaker or towards the speaker)(Please register for the seminar after registering at)

<Speakers

Mr. Kazuo Miyazaki
CEO and Representative Director, MyCan Technologies, Inc.
＜プロフィール＞
Graduated from Tokyo University of Science, Graduate School of Science. Specialized in synthetic organic chemistry and regenerative medicine. For about 20 years, he worked for a pharmaceutical company conducting exploratory research on small molecule compounds for vascular, renal, and central nervous system diseases, as well as small molecule compounds to complement regenerative medicine. His encounter with malaria, dengue fever, and other infectious diseases in India led him to establish MyCan Technologies, Inc. in 2016. The company aims to solve the challenges of infectious diseases with special blood cells using regenerative medicine technology.

Mr. Yuki Furuyama
Assistant Professor, Department of Life Science and Biological Sciences, Tokyo University of Science
＜プロフィール＞
D. in Applied Biological Science, Graduate School of Science and Engineering, Tokyo University of Science in March 2021. D. (Science). He has been an Assistant Professor in the Department of Life Science and Bioscience, Faculty of Science and Technology, Tokyo University of Science since April of the same year. Specializes in bioorganic chemistry and applied microbiology. His research interests include the analysis of microbial interaction mechanisms and the development of microbial control methods using chemical biology methods. During his doctoral studies, he was engaged in research on phytopathogenic filamentous fungi. Currently, he is mainly working on dermal commensal microorganisms.

Hiroyuki Takahashi
Director, Knowledge Foundation Research Center, Research and Development Division, Liverness, Inc. 
＜プロフィール＞
D. from Yokohama City University in 2009. D. in Science, focusing on creating new research projects between industry and young researchers, including the launch of the "Liberace Research Fund" for young researchers under the age of 40. He has also been involved in the creation of "super interdisciplinary academic societies," a place where individuals can combine their knowledge, skills, and passion for problem solving to create new knowledge without being bound by the framework of academia, and the establishment of real laboratories for knowledge manufacturing, among other activities to create seeds for research and development.

＜Inquiries regarding this matter
LIVERNESS Corporation：Kawashima, Takahashi (Hiroshi)
MAIL:[email protected]/TEL: 03-5227-4198